Results 51 to 60 of about 303,882 (203)

Executive Summary to EDC-2 : The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals

open access: yes, 2015
This Executive Summary to the Endocrine Society's second Scientific Statement on environmental endocrine-disrupting chemicals (EDCs) provides a synthesis of the key points of the complete statement.
Prins, Gail S.,   +7 more
core   +1 more source

Introduction: The ecological relevance of chemically induced endocrine disruption in wildlife [PDF]

open access: yes, 2006
This article is part of the monograph “The Ecological Relevance of Chemically Induced Endocrine Disruption in Wildlife.
Charles R. Tyler   +3 more
core   +1 more source

Quantitative MRI Assessment of Orbital Structures in Radioactive Iodine‐131 Therapy for Inactive Graves’ Ophthalmopathy

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Objective The understanding regarding the role of orbital magnetic resonance imaging (MRI) in predicting the prognosis of radioactive iodine‐131 (I‐131) therapy for patients with inactive Graves’ ophthalmopathy (GO) is limited. Therefore, this study aimed to explore the application of MRI quantitative measurements of orbital structures in radioactive I‐
Man Wang   +3 more
wiley   +1 more source

Clinical case report: combination of endocrine ophthalmopathy and myasthenia gravis: diagnostic and therapeutic difficulties [PDF]

open access: yesКлиническая офтальмология
D.S. Atarshchikov1, E.S. Taskina2, D.P. Podkopaeva3, N.I. Kibalina1 1AO GK Medsi, Moscow, Russian Federation 2Chita State Medical Academy, Chita, Russian Federation 3I.M.
D.S. Atarshchikov   +3 more
doaj  

SEARCH FOR TARGET TISSUE IN THE EYE ORBIT FOR AUTOIMMUNE AGGRESSION OF THYROID ANTIBODIES IN ENDOCRINE OPHTHALMOPATHY

open access: yesМедицинская иммунология, 2017
We searched for a possible target tissue in eye orbit for thyroid autoantibodies in endocrine ophthalmopathy (Graves’ disease), using correlation analysis method. We examined a group of 139 patients (278 eye orbits) with thyroid-associated ophthalmopathy
V. G. Likhvantseva   +4 more
doaj   +1 more source

Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Thyroid eye disease (TED) is an autoimmune inflammatory condition linked to thyroid dysfunction, which can result in disfigurement and potential vision loss. Recently, immunomodulatory therapies such as rituximab have demonstrated potential benefit in managing TED.
Ming Lu   +3 more
wiley   +1 more source

PDGFRα+DPP4+ Fibroblasts‐Macrophage Crosstalk Induces Orbital Fibrosis in Treatment‐Resistant Thyroid Eye Disease via the GAS6‐AXL Pathway

open access: yesAdvanced Science, Volume 12, Issue 45, December 4, 2025.
This study elucidates macrophage‐induced orbital fibrosis in TED via the GAS6‐AXL pathway, a treatment‐resistant disorder lacking non‐surgical therapies. Using a novel patient cell‐derived orthotopic animal model of orbital fibrosis for TED, we repurpose an existing fibrosis therapy, addressing the absence of stable models and offering a potential ...
Lu Cheng   +14 more
wiley   +1 more source

Double Filtration Plasmapheresis for Thyroid Storm With Encephalopathy: A Case Report

open access: yesJournal of Clinical Apheresis, Volume 40, Issue 5, October 2025.
ABSTRACT Thyroid storm is a life‐threatening endocrine emergency with a mortality rate of up to 17%. Standard treatment includes antithyroid drugs (ATD), β‐blockers, and glucocorticoids. However, some patients may require blood purification therapies, such as plasmapheresis, due to the ineffectiveness of standard treatments or contraindications like ...
Qisheng Lin   +5 more
wiley   +1 more source

Basic Principles of Treatment of Endocrine Ophthalmopathy. Literature review

open access: yesOftalʹmologiâ
Endocrine ophthalmopathy (EO) is one of the most common causes of exophthalmos in adults, as well as optic neuropathy resulting from orbital compartment syndrome.
I. B. Medvedev   +5 more
doaj   +1 more source

Polymorphism of Pro12Ala and C1431T PPARγin the pathogenesis of Graves' orbitopathy

open access: yesКлиническая и экспериментальная тиреоидология, 2013
AIM: to examine the association of polymorphisms Pro12Ala and C1431T PPARγwith the development of thyroid eye disease (TEO). Materials and methods. A total of 88 people: 52 patients with TEO, 36 – healthy individuals.

doaj   +1 more source

Home - About - Disclaimer - Privacy